Francine Petrides

Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk

Benoît J. Arsenault, Francine Petrides, Fatiha Tabet et al. · Journal of clinical lipidology · 2017 · 59 citations

Metabolic Syndrome, Cardiovascular Disease, Medicine +7

Elevated Plasma PCSK9 Level Is Equally Detrimental for Patients With Nonfamilial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia, Irrespective of Low-Density Lipoprotein Receptor Defects

Gilles Lambert, Francine Petrides, Mathias Chatelais et al. · Journal of the American College of Cardiology · 2014 · 58 citations · Full text

Metabolic Syndrome, Lipid Disorder, Vascular Disease +12

Proprotein convertase subtilisin–kexin type 9 is elevated in proteinuric subjects: Relationship with lipoprotein response to antiproteinuric treatment

Arjan J. Kwakernaak, Gilles Lambert, Maartje C.J. Slagman et al. · Atherosclerosis · 2012 · 56 citations

Inflammation, Lipoprotein Response, Pathology +4

RETRACTED: Plasma PCSK9 Levels and Clinical Outcomes in the TNT (Treating to New Targets) Trial

Roeland Huijgen, S. Matthijs Boekholdt, Benoît J. Arsenault et al. · Journal of the American College of Cardiology · 2012 · 54 citations

New Targets, Clinical Trials, Plasma Pcsk9 Levels +5

Apolipoprotein A-I Limits the Negative Effect of Tumor Necrosis Factor on Lymphangiogenesis

Radjesh J. Bisoendial, Fatiha Tabet, Paul P. Tak et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2015 · 14 citations · Full text